|
Market Cap (5-Jul) $1,667,200 (1,583rd) |
Close (30-Jun) $0.003 |
Volume (30-Jun) 21,427 |
Shortsold (14-Feb) 10,000,000 (0.20%) (406th) |
|
52w High $0.020 |
52w Low $0.004 |
P/E - |
EPS -0.04 |
ADR released this announcement to the ASX on 27 September 2021, 16:07. The announcement is not marked as price sensitive, and is 25 page(s) in length and 639.39kb in size.
You can view all announcements from ADR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ADR was 0.200% short sold according to ASIC data. It was ranked the 406th most shorted stock on the ASX. It remains ranked 406th as of the latest reported data (14 February 2023).
| Other Recent Announcements from ADR | |
|---|---|
| Application for quotation of securities - ADR | 28 June 2023, 16:25 |
| Change of Auditor | 27 June 2023, 9:41 |
| Notification of cessation of securities - ADR | 11 May 2023, 13:49 |
| Notice of Annual General Meeting/Proxy Form | 27 September 2021, 16:07 |
| Adherium awarded US-based AZ clinical study supply contract | 24 September 2021, 9:59 |
| Notification regarding unquoted securities - ADR | 20 September 2021, 10:42 |
| Summary of Stock Appreciation Rights terms | 20 September 2021, 10:28 |
You must be logged in to post a reply.
Adherium 